333 related articles for article (PubMed ID: 30765202)
1. IL-17 and limits of success.
Omidian Z; Ahmed R; Giwa A; Donner T; Hamad ARA
Cell Immunol; 2019 May; 339():33-40. PubMed ID: 30765202
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Saxena A; Khosraviani S; Noel S; Mohan D; Donner T; Hamad AR
Cytokine; 2015 Jul; 74(1):27-34. PubMed ID: 25481648
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 family members in health and disease.
Chung SH; Ye XQ; Iwakura Y
Int Immunol; 2021 Nov; 33(12):723-729. PubMed ID: 34611705
[TBL] [Abstract][Full Text] [Related]
4. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
5. A new target for the treatment of inflammatory bowel disease: Interleukin-37.
Jia Y; Anwaar S; Li L; Yin Z; Ye Z; Huang Z
Int Immunopharmacol; 2020 Jun; 83():106391. PubMed ID: 32208166
[TBL] [Abstract][Full Text] [Related]
6. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
7. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
9. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
[TBL] [Abstract][Full Text] [Related]
10. IL-12-and IL-23 in health and disease.
Croxford AL; Kulig P; Becher B
Cytokine Growth Factor Rev; 2014 Aug; 25(4):415-21. PubMed ID: 25130295
[TBL] [Abstract][Full Text] [Related]
11. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
Toussirot E
Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
[TBL] [Abstract][Full Text] [Related]
12. Targeting Th17 cells in autoimmune diseases.
Yang J; Sundrud MS; Skepner J; Yamagata T
Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
[TBL] [Abstract][Full Text] [Related]
13. Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials.
Deng Y; Wang Z; Chang C; Lu L; Lau CS; Lu Q
Hum Immunol; 2017 Feb; 78(2):120-128. PubMed ID: 28040536
[TBL] [Abstract][Full Text] [Related]
14. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
Roeleveld DM; Koenders MI
Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
Dallenbach K; Maurer P; Röhn T; Zabel F; Kopf M; Bachmann MF
Eur J Immunol; 2015 Apr; 45(4):1238-47. PubMed ID: 25545966
[TBL] [Abstract][Full Text] [Related]
16. IL-17 in Chronic Inflammation: From Discovery to Targeting.
Beringer A; Noack M; Miossec P
Trends Mol Med; 2016 Mar; 22(3):230-241. PubMed ID: 26837266
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17-producing γδ T (γδ17) cells in inflammatory diseases.
Akitsu A; Iwakura Y
Immunology; 2018 Dec; 155(4):418-426. PubMed ID: 30133701
[TBL] [Abstract][Full Text] [Related]
18. The role of IL 23 in the treatment of psoriasis.
Puig L
Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
[TBL] [Abstract][Full Text] [Related]
19. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases.
Kuwabara T; Ishikawa F; Kondo M; Kakiuchi T
Mediators Inflamm; 2017; 2017():3908061. PubMed ID: 28316374
[TBL] [Abstract][Full Text] [Related]
20. The role of Interleukin-32 in autoimmunity.
de Albuquerque R; Komsi E; Starskaia I; Ullah U; Lahesmaa R
Scand J Immunol; 2021 Feb; 93(2):e13012. PubMed ID: 33336406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
